Athyrium Capital invests €15 million in Medicrea via convertible bond placement
Client(s) Athyrium Capital Management LP
Jones Day represented Athyrium Capital Management LP, as sole investor, in connection with its €15 million (US$16.7 million) investment in Medicrea International SA, a manufacturer of medical devices, through the purchase of 6.75% Senior Convertible Bonds due 2020 in a private placement.